You are here
- Home
- Last 30 days trials
A Phase I Study of Oral MK-2206 in Combination with Oral AZD6244 in Patients with Locally Advanced or Metastatic Solid Tumors
- Disease
- solid tumour
- Drug Name
- AZD6244
- Generic Name
- AZD6244
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Dec 9, 2009
- Study Name
- MK2206-010-01
- Study Id
- MK2206-010-01
- ClinicalTrials.gov ID
- Not Applicable
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
